Skip to main content
Clinical Trials/NCT05510388
NCT05510388UnknownNot Applicable

High-flow Nasal Cannula Oxygenation Reduces the Incidence of Hypoxia During Gastroscopy or Colonoscopy Sedated With Propofol in High-risk Patients: a Multi Central Randomized Controlled Study

RenJi Hospital2 sites in 1 country450 target enrollmentStarted: September 1, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
450
Locations
2
Primary Endpoint
The incidence of hypoxia

Study Overview

Brief Summary

The objective of this study is to observe the preventive effects of high flow nasal oxygenation on the incidence of hypoxia during gastroscopy or colonoscopy sedated with propofol in high-risk patients.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age ranging from 18 to 80, both sexes
  • Patients receiving selective gastroscopy or colonoscopy or gastroscopy and colonoscopy procedure
  • 18 kg/m2<BMI<28kg/m2
  • The anticipated operation time of the procedure shall be less than 30min.
  • Patients should clearly understand and voluntarily participate in the study, with signed informed consent.

Exclusion Criteria

  • Patients with nasal congestion, epistaxis, recent nasal trauma, recent nasal surgery, increased intracranial pressure and skull fracture, etc. who can not tolerate high-flow nasal cannula.
  • Patients diagnosed POCD
  • Patients clearly identified difficult airway
  • Patients with mechanical ventilation
  • Patients with acute respiratory infection and asthma
  • Patients with acute upper gastrointestinal hemorrhage accompanied by shock, severe anemia, gastrointestinal obstruction accompanied by retention of gastric contents
  • Patients with aortic stenosis and carotid stenosis
  • Patients allergic to sedatives such as propofol
  • Patients without civil capacity such as cognitive dysfunction

Outcomes

Primary Outcomes

The incidence of hypoxia

Time Frame: Patients will be followed for the duration of hospital stay, an expected average of 2 hours

Hypoxia refers to 75%≤SpO2\<90%,\<60S

Secondary Outcomes

  • Complications related to high-flow nasal cannula(Patients will be followed for the duration of hospital stay, an expected average of 2 hours)
  • The incidence of subclinical respiratory depression(Patients will be followed for the duration of hospital stay, an expected average of 2 hours)
  • Other adverse events evaluated by the tool of World SIVA(Patients will be followed for the duration of hospital stay, an expected average of 2 hours)
  • The incidence of severe hypoxia(Patients will be followed for the duration of hospital stay, an expected average of 2 hours)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials